The Experts below are selected from a list of 285 Experts worldwide ranked by ideXlab platform
A. Della Rossa - One of the best experts on this subject based on the ideXlab platform.
-
Systemic sclerosis: a critical digest of the Recent Literature.
Clinical and experimental rheumatology, 2014Co-Authors: S Barsotti, Serena Guiducci, Silvia Bellando Randone, A. Della RossaAbstract:Systemic sclerosis is a complex disease characterised by chronic multisystem involvement of internal organs; every year many studies are published on the diagnosis, pathogenesis and treatment of the disease. In this article, we provide a critical analysis of the Recent Literature on systemic sclerosis, with particular focus on the most relevant studies published over the last two years.
-
Systemic vasculitis: an annual critical digest of the most Recent Literature.
Clinical and experimental rheumatology, 2014Co-Authors: A. Della Rossa, Elena Elefante, Francesco Ferro, E. Cioffi, Alice Parma, R. Vagelli, Rosaria TalaricoAbstract:Herewith we provide our annual digest of the Recent Literature on systemic vasculitis in which we reviewed all the articles published during the last 12 months on large-, medium- and small-vessel vasculitis, and selected the most relevant studies regarding the epidemiology, pathogenesis and management of systemic vasculitis. In particular, we focused the attention on giant cell arteritis, ANCA-associated vasculitis and cryoglobulinaemia.
-
Systemic sclerosis: a critical digest of the Recent Literature.
Clinical and experimental rheumatology, 2013Co-Authors: Chiara Tani, Silvia Bellando Randone, Serena Guiducci, A. Della RossaAbstract:Herewith we provide a critical digest of the Recent Literature on systemic sclerosis. The most relevant studies published over the last two years have been reviewed, with particular focus on the diagnosis, pathogenesis and treatment of the disease.
-
Systemic vasculitis: a critical digest of the Recent Literature.
Clinical and Experimental Rheumatology, 2013Co-Authors: Rosaria Talarico, Chiara Baldini, Chiara Tani, A. Della Rossa, Linda Carli, Stefano BombardieriAbstract:Herewith we provide a critical digest of the Recent Literature on systemic vasculitis. In this manuscript, we reviewed all the articles published during the last 12 months on large-, medium- and small-vessel vasculitis and selected the most relevant studies regarding the epidemiology, pathogenesis and management of systemic vasculitis. In particular we focused the attention on giant cell arteritis, ANCA-associated vasculitis and cryoglobulinemia.
Lauren M. Osborne - One of the best experts on this subject based on the ideXlab platform.
-
Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature
Current psychiatry reports, 2018Co-Authors: Katherine Mcevoy, Jennifer L. Payne, Lauren M. OsborneAbstract:The purpose of this review is to provide a theoretical explanation and a review of the Recent Literature concerning the role of neuroactive steroids in perinatal depression, and to use this information to suggest future directions of research. The bulk of the evidence on neuroactive steroids in perinatal depression concerns allopregnanolone. Recent studies have been mixed, with some studies finding a direct correlation between lower levels of allopregnanolone and increased depressive symptoms but other studies finding no relationship. Evidence concerning other neuroactive steroids and perinatal depression is sparse. Additional research is needed with larger sample sizes and better characterization across the perinatal period (rather than cross-sectionally). Because some studies point to a lag between neuroactive steroid dysregulation and subsequent symptoms, future research should consider interactions with other aspects of neuroactive steroid physiology, such as synthetic enzymes or receptor plasticity.
-
Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature
Current Psychiatry Reports, 2018Co-Authors: Katherine Mcevoy, Jennifer L. Payne, Lauren M. OsborneAbstract:Purpose of Review The purpose of this review is to provide a theoretical explanation and a review of the Recent Literature concerning the role of neuroactive steroids in perinatal depression, and to use this information to suggest future directions of research. Recent Findings The bulk of the evidence on neuroactive steroids in perinatal depression concerns allopregnanolone. Recent studies have been mixed, with some studies finding a direct correlation between lower levels of allopregnanolone and increased depressive symptoms but other studies finding no relationship. Evidence concerning other neuroactive steroids and perinatal depression is sparse. Summary Additional research is needed with larger sample sizes and better characterization across the perinatal period (rather than cross-sectionally). Because some studies point to a lag between neuroactive steroid dysregulation and subsequent symptoms, future research should consider interactions with other aspects of neuroactive steroid physiology, such as synthetic enzymes or receptor plasticity.
Rolando Leal - One of the best experts on this subject based on the ideXlab platform.
-
Secondary Sclerosing Cholangitis: a Review of Recent Literature
Current Gastroenterology Reports, 2017Co-Authors: John Brooling, Rolando LealAbstract:Purpose of Review Secondary sclerosing cholangitis is an emerging entity. Yet, because of the low incidence and varying etiologies of this disease, the Literature is not robust. There are mainly case reports and small studies evaluating the disease. Our aim in this review is to bring the reader up to date with Recent Literature on secondary sclerosing cholangitis including the disease presentation, course, prognosis, and treatment options. Recent Findings Numerous case reports have been published the last 5 years on secondary sclerosing cholangitis. We have divided them into infectious, drug-induced, ischemic, obstructive, and autoimmune etiologies. The bulk of the Literature describes secondary sclerosing cholangitis in the critically ill patient. Summary Secondary sclerosing cholangitis due to drugs or autoimmune causes seem to have the best prognosis. However, causes such as critical illness seem to have worse outcomes.
-
Secondary Sclerosing Cholangitis: a Review of Recent Literature.
Current gastroenterology reports, 2017Co-Authors: John Brooling, Rolando LealAbstract:Purpose of Review Secondary sclerosing cholangitis is an emerging entity. Yet, because of the low incidence and varying etiologies of this disease, the Literature is not robust. There are mainly case reports and small studies evaluating the disease. Our aim in this review is to bring the reader up to date with Recent Literature on secondary sclerosing cholangitis including the disease presentation, course, prognosis, and treatment options.
Rosaria Talarico - One of the best experts on this subject based on the ideXlab platform.
-
Systemic vasculitides: a critical digest of the most Recent Literature.
Clinical and experimental rheumatology, 2015Co-Authors: Chiara Stagnaro, Rosaria Talarico, E. Cioffi, Della Rossa AAbstract:Herewith we provide our annual digest of the Recent Literature on systemic vasculitides. In this manuscript, we reviewed all the articles published during the last 12 months on large-, medium- and small-vessel vasculitis and selected the most relevant studies regarding the epidemiology, pathogenesis and management of systemic vasculitis. In particular, we focused the attention on giant cell arteritis, ANCA-associated vasculitis and cryoglobulinaemia.
-
Systemic vasculitis: an annual critical digest of the most Recent Literature.
Clinical and experimental rheumatology, 2014Co-Authors: A. Della Rossa, Elena Elefante, Francesco Ferro, E. Cioffi, Alice Parma, R. Vagelli, Rosaria TalaricoAbstract:Herewith we provide our annual digest of the Recent Literature on systemic vasculitis in which we reviewed all the articles published during the last 12 months on large-, medium- and small-vessel vasculitis, and selected the most relevant studies regarding the epidemiology, pathogenesis and management of systemic vasculitis. In particular, we focused the attention on giant cell arteritis, ANCA-associated vasculitis and cryoglobulinaemia.
-
Systemic vasculitis: a critical digest of the Recent Literature.
Clinical and Experimental Rheumatology, 2013Co-Authors: Rosaria Talarico, Chiara Baldini, Chiara Tani, A. Della Rossa, Linda Carli, Stefano BombardieriAbstract:Herewith we provide a critical digest of the Recent Literature on systemic vasculitis. In this manuscript, we reviewed all the articles published during the last 12 months on large-, medium- and small-vessel vasculitis and selected the most relevant studies regarding the epidemiology, pathogenesis and management of systemic vasculitis. In particular we focused the attention on giant cell arteritis, ANCA-associated vasculitis and cryoglobulinemia.
Katherine Mcevoy - One of the best experts on this subject based on the ideXlab platform.
-
Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature
Current psychiatry reports, 2018Co-Authors: Katherine Mcevoy, Jennifer L. Payne, Lauren M. OsborneAbstract:The purpose of this review is to provide a theoretical explanation and a review of the Recent Literature concerning the role of neuroactive steroids in perinatal depression, and to use this information to suggest future directions of research. The bulk of the evidence on neuroactive steroids in perinatal depression concerns allopregnanolone. Recent studies have been mixed, with some studies finding a direct correlation between lower levels of allopregnanolone and increased depressive symptoms but other studies finding no relationship. Evidence concerning other neuroactive steroids and perinatal depression is sparse. Additional research is needed with larger sample sizes and better characterization across the perinatal period (rather than cross-sectionally). Because some studies point to a lag between neuroactive steroid dysregulation and subsequent symptoms, future research should consider interactions with other aspects of neuroactive steroid physiology, such as synthetic enzymes or receptor plasticity.
-
Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature
Current Psychiatry Reports, 2018Co-Authors: Katherine Mcevoy, Jennifer L. Payne, Lauren M. OsborneAbstract:Purpose of Review The purpose of this review is to provide a theoretical explanation and a review of the Recent Literature concerning the role of neuroactive steroids in perinatal depression, and to use this information to suggest future directions of research. Recent Findings The bulk of the evidence on neuroactive steroids in perinatal depression concerns allopregnanolone. Recent studies have been mixed, with some studies finding a direct correlation between lower levels of allopregnanolone and increased depressive symptoms but other studies finding no relationship. Evidence concerning other neuroactive steroids and perinatal depression is sparse. Summary Additional research is needed with larger sample sizes and better characterization across the perinatal period (rather than cross-sectionally). Because some studies point to a lag between neuroactive steroid dysregulation and subsequent symptoms, future research should consider interactions with other aspects of neuroactive steroid physiology, such as synthetic enzymes or receptor plasticity.
